Breast cancer
Women
- New cases in 2024
- 1,494
- Deaths in 2024
- 656
- Five-year prevalence
- 3,227
Reduce your risk. Recognise changes. Seek help early.
Practical information for people and families in Papua New Guinea, focusing on oral, cervical and breast cancers.
Cancer in Papua New Guinea · 2024 estimates
Breast, oral and cervical cancers are the focus of our public awareness guides. These figures describe the estimated national burden across PNG, rather than the number of patients seen at PMGH.
All cancers in PNG
13,908
New cases in 2024
All cancers in PNG
7,785
Deaths in 2024
All cancers in PNG
27,096
Five-year prevalence
All-cancer totals include non-melanoma skin cancer. Figures are estimates, not a complete count of diagnosed cases.
Women
Women and men · Lip and oral cavity
Women
Rates below are per 100,000 people, adjusted to the same world standard age distribution. This accounts for differences in population size and age. Breast and cervical rates are per 100,000 women; oral cancer rates include women and men. Both countries use GLOBOCAN 2024 estimates.
Women · rates per 100,000
New cases · age-adjusted rate
Deaths · age-adjusted rate
Five-year prevalence · people
These are counts, not age-adjusted rates.
Women and men · rates per 100,000
New cases · age-adjusted rate
Deaths · age-adjusted rate
Five-year prevalence · people
These are counts, not age-adjusted rates.
Women · rates per 100,000
New cases · age-adjusted rate
Deaths · age-adjusted rate
Five-year prevalence · people
These are counts, not age-adjusted rates.
Bars share a scale within each measure: 0–110 for new cases and 0–20 for deaths. Differences also reflect detection, registration and estimation methods; these figures do not measure an individual’s chance of survival.
Incidence: new cancer cases estimated during 2024. Mortality: deaths from cancer estimated during 2024.
Five-year prevalence: people estimated to be alive who were diagnosed in the previous five years. It includes people receiving treatment and those who have completed treatment; it is not a five-year survival percentage.
National estimates: IARC models PNG incidence using national mortality estimates and modelled mortality-to-incidence ratios, because suitable incidence data are unavailable. Australia’s estimates use cancer registry and mortality data projected to 2024. PNG estimates carry substantial uncertainty and may differ from the cases seen in a particular hospital.
Deaths in one year and new diagnoses in that year are different groups of people. Dividing deaths by new cases does not give a mortality or survival percentage.
Sources: IARC GLOBOCAN 2024 · PNG fact sheet (PDF) · Australia fact sheet (PDF) · Cancer Today rates. Sources checked 12 October 2026.
Reduce risks before cancer develops. You cannot prevent every cancer, and a diagnosis is not your fault.
Checks for cancer or changes before cancer develops in people who have no symptoms. Abnormal results need follow-up.
Get a new or persistent change assessed. Do not wait for a screening appointment if you have symptoms.
Mouth, tongue, gums and lips
Stopping betel nut and tobacco use is an important step towards protecting your mouth.
A trained health worker or dentist can examine your mouth for concerning changes. Ask about an examination, especially if you use betel nut or tobacco. Looking in a mirror does not replace a professional assessment.
See a doctor or dentist for these changes. They can arrange assessment by the relevant head-and-neck, ENT or oral surgical service if needed. Do not wait three weeks to seek help for a lump or difficulty swallowing.
The cervix is the opening of the womb
HPV vaccination and screening can prevent many cervical cancers. Changes before cancer develops often have no symptoms.
HPV testing looks for the virus that can cause cervical changes. Other tests may be used depending on the service. Ask your clinic when to start and how often to return; people living with HIV need earlier and more frequent screening. Follow up any abnormal result.
See a health worker promptly for these symptoms, even after a normal screening result. They can arrange gynaecological assessment. An abnormal screening test does not necessarily mean cancer.
Patient awareness guide
Cervical screening: what to expectLearn about the visit, possible tests and follow-up. Your local provider will confirm available services.
Prevention in PNG
WHO’s announcement of 8 September 2026 describes a single-dose programme for girls aged 9–14. Free Phase 1 vaccination is scheduled for November 2026 in NCD and Central Province, with other provinces to follow.
Parents and caregivers should follow announcements from schools, health facilities and outreach teams for local dates and eligibility. Girls who are not in school are also included in the planned outreach.
Cervical screening in PNG
The Sir Brian Bell Foundation and CPL Foundation describe a cervical screening service with a fee of K20, same-day results and treatment where appropriate, and referral when further care is needed.
Check directly with the provider for the current location, opening times, fee and who can attend before travelling.
Know what is usual for your breasts
A new breast change needs assessment, even if it is painless or there is no family history of cancer. Men can develop breast cancer too.
Mammography is an X-ray used to screen people without symptoms. Discuss your age, family history and the benefits and limitations with a clinician. The appropriate schedule and local availability need to be confirmed. Breast awareness is not a substitute for mammography when it is recommended.
Arrange a medical assessment for a new change. Your clinician can refer you to the breast or surgical service for examination and tests. Many lumps are not cancer, but a painless lump still needs checking.
Patient awareness guide
Breast screening: what to expectLearn about the visit, possible tests and follow-up. Your local provider will confirm available services.
These symptoms can have other causes. Checking them early helps a clinician find out what is happening and arrange the right care.
The PMGH oncology referral portal is for confirmed cancer. It is not the route for initial assessment of suspected cancer.
Clinical operations commencing in December 2026. Clinical services have not yet commenced.
Not necessarily. Many breast lumps have other causes, and a screening result needs follow-up to find out what it means. See a clinician rather than trying to diagnose yourself.
Yes. Vaccination and screening work together. Follow the screening advice from your health service, and get symptoms assessed even if you have been vaccinated.
No. Screening is for people without symptoms. Arrange a medical assessment for a new or persistent change, even if a previous screening test was normal.
Sources checked: 12 October 2026. General health information, not an individual diagnosis or screening prescription. Local service details may change; check with the provider.
International guidance supports the explanations above. Your clinician and local health programme determine which screening tests and schedules are appropriate for you.